文献速递产科

妊娠中期药物流产引产时长与不良结局的关系

Duration of Induction of Labor for Second-Trimester Medication Abortion and Adverse Outcomes.
PubMed 文献 · Obstet Gynecol · 2024-07-11

这项回顾性队列研究纳入四中心681例无晚期宫颈扩张、胎膜破裂或早产征象的单胎妊娠中期药物流产者,主要暴露为从接受米索前列醇到胎儿排出的引产时长。引产时长中位数11小时,19.2%发生复合并发症;引产时长≥17小时者复合并发症风险升高(校正相对风险1.99,95%CI 1.34-2.96),临床绒毛膜羊膜炎在长时长组与短时长组间差异显著(26.2% vs 10.6%,P<.001)。

要点

  • 妊娠中期药物流产引产时长中位数为11小时(四分位距8-17小时)。
  • 引产时长≥17小时者复合并发症风险升高(校正相对风险1.99,95%CI 1.34-2.96)。
  • 临床绒毛膜羊膜炎在长时长组与短时长组间差异显著(26.2% vs 10.6%,P<.001)。

核心结论

  • 引产时长与妊娠中期药物流产的不良母体结局独立相关,尤其是临床绒毛膜羊膜炎。

研究设计与样本

  • 回顾性队列研究,纳入四中心681例无晚期宫颈扩张、胎膜破裂或早产征象的单胎妊娠中期药物流产者。
  • 主要暴露为引产时长,即从接受米索前列醇到胎儿排出的小时数。
  • 主要结局为复合并发症,包括子宫破裂、需要输血、临床绒毛膜羊膜炎、入住重症监护室或需要再入院。
  • 采用双变量和多变量负二项分析,并按孕周进行事后亚组分析,基于子宫瘢痕史和产次进行同质性检验。

主要发现

  • 681例中131例(19.2%)发生主要结局。
  • 引产时长连续评估时,较长引产时长与并发症频率增加相关(校正β=0.68,95%CI 0.32-1.04)。
  • 引产时长分类评估时,最高四分位(即17小时或以上)者发生并发症的风险显著高于其他所有四分位者(校正相对风险1.99,95%CI 1.34-2.96)。
  • 临床绒毛膜羊膜炎在较长引产时长者与较短引产时长者间差异显著(26.2% vs 10.6%,P<.001)。
  • 亚组分析中,孕周与复合并发症风险无关;同质性检验显示有子宫瘢痕史者或基于产次的并发症风险无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the relationship between duration of labor during second-trimester medication abortion and adverse outcomes. METHODS: We conducted a retrospective cohort study including all individuals with a singleton gestation undergoing second-trimester medication abortion without evidence of advanced cervical dilation, rupture of membranes, or preterm labor at four centers. The primary exposure was duration of labor (ie, hours spent from receiving misoprostol to fetal expulsion). The primary outcome was composite morbidity , defined as uterine rupture, need for blood transfusion, clinical chorioamnionitis, intensive care unit admission, or need for readmission. We performed bivariate and multivariate negative binomial analyses. A post hoc subgroup analysis was performed to assess for the risk of the primary outcome by gestational age. We performed tests of homogeneity based on history of uterine scarring and parity. RESULTS: Six hundred eighty-one individuals were included. The median duration of labor was 11 hours (interquartile range 8-17 hours). One hundred thirty-one (19.2%) experienced the primary outcome. When duration of labor was evaluated continuously, a longer duration of labor was associated with an increased frequency of morbidity (adjusted β=0.68, 95% CI, 0.32-1.04). When duration of labor was evaluated categorically, those experiencing the highest quartile of duration (ie, 17 hours or more) had a statistically higher risk for experiencing morbidity compared with individuals in all other quartiles (adjusted relative risk 1.99, 95% CI, 1.34-2.96). When we focused on components of the composite outcome, clinical chorioamnionitis was significantly different between those experiencing a longer duration and those experiencing a shorter duration of labor (26.2% vs 10.6%, P <.001). On subgroup analysis, gestational age was not associated with the risk of composite morbidity. Tests of homogeneity demonstrated no significant difference in the risk for morbidity among individuals with a history of uterine scarring or based on parity. CONCLUSION: Duration of labor was independently associated with risks for adverse maternal outcomes during second-trimester medication abortion, specifically clinical chorioamnionitis.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Premkumar A, Manthena V, Wascher J, et al. Duration of Induction of Labor for Second-Trimester Medication Abortion and Adverse Outcomes. Obstet Gynecol. 2024. PMID: 38991214. doi:10.1097/AOG.0000000000005663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。